Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Spanish researchers have identified a promising new class of drugs—led by Ruvid (a dual-acting glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist)—that may slow the dual damage to the heart and ... Read More
Continuous Coverage
A Peabody, Massachusetts, man pleaded guilty to fraudulently obtaining over $100,000 in federal coronavirus relief funds, exposing systemic…
Knoxville-bred singer-songwriter Greylan James is rapidly transitioning from Nashville’s best-kept secret—a prolific pen behind hits for Kenny Chesney…
Football in the rain demands tactical recalibration, physical resilience, and a redefinition of expected goals (xG). As teams…
As Dragon Quest celebrates its 40th anniversary this week, the franchise stands as a foundational architecture for modern…
BP (NYSE: BP) has terminated Chairman Albert Manifold effective immediately following internal investigations into allegations of bullying and…
The fragile ceasefire in Lebanon has unraveled with alarming speed, as Israeli forces escalate strikes against Hezbollah strongholds…
Global Affairs
Poland’s government has imposed a 21-day mandatory quarantine for travelers from high-risk regions amid a resurgent Ebola outbreak…
Markets And Money
/data/photo/2023/06/09/64827fdbd2ef2.jpg)
Meta Platforms (NASDAQ: META) CEO Mark Zuckerberg announced a new compensation package for remaining employees—including a 10% equity…
Digital Culture
Bank Expansion in Sandnessjøen Reflects Digital-First Financial Infrastructure Local bank branches in Sandnessjøen and Brønnøysund are rolling out…
Science And Wellbeing
Ozempic’s GLP-1 Revolution: A Public Health Shift or Overhyped Trend? In 2026, Ozempic (semaglutide) has emerged as a…
Screen And Sound
As Eurovision celebrates its 70th anniversary this week, Ireland’s legendary winners have reunited for a commemorative video broadcast…
Fixtures And Form
Jannik Sinner secured a clinical first-round victory at the 2026 French Open, reaffirming his status as the tournament…
